Springe direkt zu Inhalt

586. MIF does only marginally enhance the pro-regenerative capacities of DFO in a mouse-osteotomy-model of compromised bone healing conditions

A. Lang, J. Stefanowski, M. Pfeiffenberger, A. Wolter, A. Damerau, S. Hemmati-Sadeghi, R. Haag, A. Hauser, M. Löhning, G. N. Duda, P. Hoff, K. Schmidt-Bleek, T. Gaber, F. Buttgereit – 2022

The initial phase of fracture healing is crucial for the success of bone regeneration and is characterized by an inflammatory milieu and low oxygen tension (hypoxia). Negative interference with or prolongation of this fine-tuned initiation phase will ultimately lead to a delayed or incomplete healing such as non-unions which then requires an effective and gentle therapeutic intervention. Common reasons include a dysregulated immune response, immunosuppression or a failure in cellular adaptation to the inflammatory hypoxic milieu of the fracture gap and a reduction in vascularizing capacity by environmental noxious agents (e.g. rheumatoid arthritis or smoking). The hypoxia-inducible factor (HIF)-1α is responsible for the cellular adaptation to hypoxia, activating angiogenesis and supporting cell attraction and migration to the fracture gap. Here, we hypothesized that stabilizing HIF-1α could be a cost-effective and low-risk prevention strategy for fracture healing disorders. Therefore, we combined a well-known HIF-stabilizer - deferoxamine (DFO) - and a less known HIF-enhancer - macrophage migration inhibitory factor (MIF) - to synergistically induce improved fracture healing. Stabilization of HIF-1α enhanced calcification and osteogenic differentiation of MSCs in vitro. In vivo, only the application of DFO without MIF during the initial healing phase increased callus mineralization and vessel formation in a preclinical mouse-osteotomy-model modified to display a compromised healing. Although we did not find a synergistically effect of MIF when added to DFO, our findings provide additional support for a preventive strategy towards bone healing disorders in patients with a higher risk by accelerating fracture healing using DFO to stabilize HIF-1α.

Title
586. MIF does only marginally enhance the pro-regenerative capacities of DFO in a mouse-osteotomy-model of compromised bone healing conditions
Author
A. Lang, J. Stefanowski, M. Pfeiffenberger, A. Wolter, A. Damerau, S. Hemmati-Sadeghi, R. Haag, A. Hauser, M. Löhning, G. N. Duda, P. Hoff, K. Schmidt-Bleek, T. Gaber, F. Buttgereit
Date
2022
Identifier
DOI: 10.1016/j.bone.2021.116247
Source(s)
Citation
Bone, 2022, 154, 116247
Type
Text